systemic abnormalities in migraine what comes first?

Neurologist

Volumn 15, Issue 2, 2009, Pages 53-54

  Marmura, Michael J ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Adiponectin; C reactive protein; Metabolic syndrome; Migraine; Neuropeptide Y

Indexed keywords

C REACTIVE PROTEIN; NEUROPEPTIDE Y;

DISEASE PREDISPOSITION; GENETIC PREDISPOSITION; INFLAMMATION; METABOLIC SYNDROME X; MIGRAINE; NOTE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; VASODILATATION;

EID: 63449113688     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e31817781e0     Document Type: Note

References (23)

1. Loder E, Harrington MG, Cutrer M, et al. Selected confirmed, probable, and exploratory migraine biomarkers. Headache. 2006;46:1108-1127.
2. Tietjen GE, Al-Qasmi MM, Shukairy MS. Livedo reticularis and migraine: a marker for stroke risk? Headache. 2002;42:352-355.
3. Biary N, Koller W, Langenberg P. Correlation between essential tremor and migraine headache. J Neurol Neurosurg Psychiatry. 1990;53:1060-1062.
4. Adeney KL, Williams MA. Migraine headaches and preeclampsia: an epidemiologic review. Headache. 2006;46:794-803.
5. Gretchen ET. Migraine as a systemic disorder. Neurology. 2007;68:1555-1556.
6. Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology. 2006;66:545-550.
7. Weder-Cisneros ND, Téllez-Zenteno JF, Cardiel MH, et al. Prevalence and factors associated with headache in patients with systemic lupus erythematosus. Cephalalgia. 2004;24:1031-1044.
8. Jacome DE. Headache in Ehlers-Danlos syndrome. Cephalalgia. 1999;19: 791-796.
9. Hagen K, Stovner LJ, Vatten L, et al. Blood pressure and risk of headache: a prospective study of 22,685 adults in Norway. J Neurol Neurosurg Psychiatry. 2002;72:463-466.
10. Thijs RD, Kruit MC, van Buchem MA, et al. Syncope in migraine: the population-based CAMERA study. Neurology. 2006;66:1034-1037.
11. Guldiken B, Guldiken S, Taskiran B, et al. Migraine in metabolic syndrome. Neurologist. 2008.
12. Cavestro C, Rosatello A, Micca G, et al. Insulin metabolism is altered in migraineurs: a new pathogenic mechanism for migraine? Headache. 2007; 47:1436-1442.
13. Perciaccante A, Perciaccante MV. Autonomic nervous system, insulin, and migraine. Headache. 2008;48:1381-1382.
14. Young WB, Rozen TD. Preventive treatment of migraine: effect on weight. Cephalalgia. 2005;25:1-11.
15. Reynolds MF, Sisk EC, Rasgon NL. Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review. Curr Med Chem. 2007;14:2799-2812.
16. Rainero I, Ferrero M, Rubino E, et al. Endocrine function is altered in chronic migraine patients with medication-overuse. Headache. 2006;46: 597-603.
17. Welch KM, Brandes AW, Salerno L, et al. C-reactive protein may be increased in migraine patients who present with complex clinical features. Headache. 2006;46:197-199.
18. Peterlin BL, Bigal ME, Tepper SJ, et al. Migraine and adiponectin: is there a connection? Cephalalgia. 2007;27:435-446.
19. Benson H, Greenwood MM. Metabolic changes during the prodrome of a migraine headache. Headache. 1978;17:248-249.
20. Shaw SW, Johnson RH, Keogh HJ. Metabolic changes during glucose tolerance tests in migraine attacks. J Neurol Sci. 1977;33:51-59.
21. Valenzuela RF, Donoso MV, Mellado PA, et al. Migraine, but not subarachnoid hemorrhage, is associated with differentially increased NPY-like immunoreactivity in the CSF. J Neurol Sci. 2000;173:140-146.
22. Rozen T, Swidan SZ. Elevation of CSF tumor necrosis factor alpha levels in new daily persistent headache and treatment refractory chronic migraine. Headache. 2007;47:1050-1055.
23. Tietjen GE, Herial NA, Hardgrove J, et al. Migraine comorbidity constellations. Headache. 2007;47:857-865.